Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
BCK Capital Management LP (CIK 1819275) reported $23.0M across 21 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: MBAV ($4.2M, 18.15%), CEPO ($4.1M, 17.75%), YORKU ($3.8M, 16.69%), WBD ($1.9M, 8.13%), EA ($1.4M, 6.22%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | MBAV | M3BRIGADE ACQUISITION V CORP | $4.2M | 18.15% | 388,000 | Hold |
| 2 | CEPO | CANTOR EQUITY PARTNERS I INC | $4.1M | 17.75% | 388,000 | Hold |
| 3 | YORKU | YORKVILLE ACQUISITION CORP. | $3.8M | 16.69% | 379,000 | Hold |
| 4 | WBD | WARNER BROS DISCOVERY INC | $1.9M | 8.13% | 68,000 | New |
| 5 | EA | ELECTRONIC ARTS INC | $1.4M | 6.22% | 7,000 | New |
| 6 | GTLS | CHART INDS INC | $1.1M | 4.95% | 5,500 | New |
| 7 | HOLX | HOLOGIC INC | $1.1M | 4.61% | 14,000 | New |
| 8 | JHG | JANUS HENDERSON GROUP PLC | $882,023 | 3.84% | 17,170 | New |
| 9 | ACLX | ARCELLX INC | $459,280 | 2.00% | 4,000 | New |
| 10 | AES | AES CORP | $422,700 | 1.84% | 30,000 | New |
| 11 | SEE | SEALED AIR CORP NEW | $420,500 | 1.83% | 10,000 | New |
| 12 | UNF | UNIFIRST CORP MASS | $402,544 | 1.75% | 1,600 | New |
| 13 | ACI | ALBERTSONS COS INC | $370,279 | 1.61% | 21,730 | Trimmed |
| 14 | APLS | APELLIS PHARMACEUTICALS INC | $321,840 | 1.40% | 8,000 | New |
| 15 | IMXI | INTERNATIONAL MONEY EXPRESS | $316,000 | 1.38% | 20,000 | New |
| 16 | DBRG | DIGITALBRIDGE GROUP INC | $308,400 | 1.34% | 20,000 | New |
| 17 | NATH | NATHANS FAMOUS INC | $302,190 | 1.32% | 3,000 | New |
| 18 | TPH | TRI POINTE HOMES INC | $303,745 | 1.32% | 6,500 | New |
| 19 | ONTF | ON24 INC | $299,700 | 1.31% | 37,000 | New |
| 20 | CWAN | CLEARWATER ANALYTICS HLDGS I | $295,625 | 1.29% | 12,500 | New |
| 21 | FOLD | AMICUS THERAPEUTIC | $289,200 | 1.26% | 20,000 | New |
| 22 | BACQ | INFLECTION POINT ACQUISITION | $0 | 0.00% | 0 | Exited |
| 23 | CCIX | CHURCHILL CAPITAL CORP IX | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2026-03-31